Evidence map›Paper›PMID 41142377›Full record

ArticleMolecular therapy. Nucleic acids2025

Infection-sensing minigenome as a novel therapeutic approach against Ebola virus.

Lin Wang, Brady N Zell, Brian J Parrett, Michael A Barry, Satoko Yamaoka

Abstract read
In one paragraph

Article in Molecular therapy. Nucleic acids, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Lin WangDivision of Infectious Diseases, Department of Medicine, Mayo Clinic, Rochester, MN, USA.
Brady N ZellVirology and Gene Therapy Program, Mayo Clinic Graduate School of Biomedical Sciences, Rochester, MN, USA.
Brian J ParrettVirology and Gene Therapy Program, Mayo Clinic Graduate School of Biomedical Sciences, Rochester, MN, USA.
Michael A BarryDivision of Infectious Diseases, Department of Medicine, Mayo Clinic, Rochester, MN, USA.
Satoko YamaokaDivision of Infectious Diseases, Department of Medicine, Mayo Clinic, Rochester, MN, USA.

Funding

PhD Training Program in Virology and Gene TherapyT32AI132165 · NIAID · MAYO CLINIC ROCHESTER · PI ROBERTO B. CATTANEO · 2018 to 2026
$1.3M
NIAID NIH HHS T32 AI132165
6 · The paper itself

Abstract

We describe here a molecular therapy that uses the virus's own proteins to combat itself. In this approach, infection-sensing RNAs encoding therapeutic genes are flanked by viral promoters and packaging signals in negative-sense orientation. These therapeutic minigenome RNAs do not express the transgene and remain silent in the absence of a viral infection. In contrast, if the cell is infected, the virus acts as a helper virus, providing viral proteins

Indexed as

antiviral therapyebola virusfilovirusMT: Oligonucleotides: Therapies and Applicationsnegative-strandpositive-strand

Identifiers

PMID41142377
PMCPMC12546956

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.